BriefMeBro is now free — every edition, no signup. briefmebro.com
BRIEFMEBRO· The 30-second world & markets brief — including the stories they buried.
45FINANCE

GE HealthCare in talks to acquire cancer-scan chemical maker Sofie Biosciences for over $1 billion

⚡ Markets: A significant bolt-on acquisition for GE HealthCare, strengthening its position in the molecular imaging and oncology diagnostics market. Positive for GEHC stock if the deal is seen as strategically sound and accretive.GEHC

According to the Financial Times, GE HealthCare is in discussions for a potential acquisition of Sofie Biosciences, a US-based company that manufactures chemicals used in cancer scans. The deal is reportedly valued at over $1 billion.

West MSM 1Financial press 11 country
2 sources across the spectrum
Financial pressFinancial Times — GE HealthCare in talks over $1bn deal for maker of cancer scan chemicals
West MSMReuters — GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports
← Full brief